In a historic move, on October 6, 2022, President Joe Biden announced a three-step program to bring broad changes to federal cannabis policy. As an initial step towards reform, President Biden will pardon all federal...more
10/7/2022
/ Biden Administration ,
Cannabis Products ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Deregulation ,
Legislative Agendas ,
Marijuana ,
Presidential Pardons ,
Presidential Proclamations ,
Regulatory Agenda ,
Regulatory Reform ,
Wrongful Conviction
On May 4, 2022, the Food and Drug Administration (FDA) issued warning letters to five companies it asserts are illegally marketing products labeled as containing delta-8 tetrahydrocannabinol (Delta-8 THC) in ways that violate...more
On Thursday, March 24, 2022, the Senate unanimously passed the CMRE Act (Cannabidiol and Marihuana Research Expansion Act) and House leadership scheduled the MORE Act (Marijuana Opportunity and Expungement Act) for a floor...more
In a win for much of the booming hemp products industry, on October 6, 2021, California Governor Gavin Newsom signed AB-45 into law. AB-45 is comprehensive legislation that regulates and legitimizes many industrial hemp...more
On January 15, 2021, the U.S. Department of Agriculture (USDA) announced the publication of its hemp production Final Rule in the Federal Register. The Final Rule will go into effect on March 22, 2021. The Final Rule largely...more
On October 29, 2019, the U.S. Department of Agriculture (USDA) released its long-awaited interim final rule governing the U.S. Domestic Hemp Production Program. USDA has been developing these interim regulations since hemp...more
10/31/2019
/ Agricultural Sector ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Decriminalization of Marijuana ,
Farm Bill ,
Hemp ,
Interim Final Rules (IFR) ,
Interstate Commerce ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
State and Local Government ,
Tribal Governments ,
USDA
On September 26, 2019, the US Food and Drug Administration (FDA) published six guidance documents clarifying its scope of authority and enforcement discretion policies in light of the 21st Century Cures Act (Cures Act). The...more
10/1/2019
/ 21st Century Cures Act ,
Artificial Intelligence ,
Electronic Medical Records ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Innovative Technology ,
Machine Learning ,
Medical Devices ,
New Guidance ,
Prescription Drugs ,
Regulatory Requirements
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not)...more